Limb blood flow during exercise is dependent on nitric oxide

We have recently reported that hypercholesterolemia reduces aerobic exercise capacity in mice and that this is associated with a reduced endothelium-dependent vasodilator function, endothelium-derived nitric oxide (EDNO) production, and urinary nitrate excretion. These findings led us to test the hy...

Full description

Saved in:
Bibliographic Details
Published inCirculation (New York, N.Y.) Vol. 98; no. 4; pp. 369 - 374
Main Authors MAXWELL, A. J, SCHAUBLE, E, BERNSTEIN, D, COOKE, J. P
Format Journal Article
LanguageEnglish
Published Hagerstown, MD Lippincott Williams & Wilkins 28.07.1998
American Heart Association, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract We have recently reported that hypercholesterolemia reduces aerobic exercise capacity in mice and that this is associated with a reduced endothelium-dependent vasodilator function, endothelium-derived nitric oxide (EDNO) production, and urinary nitrate excretion. These findings led us to test the hypothesis that EDNO production contributes significantly to limb blood flow during exercise and to determine whether loss of EDNO production is responsible for the decline in exercise capacity observed in hypercholesterolemia. Twelve-week-old wild-type (E+; n=9) and apoE-deficient (E-; n=9) C57BL/6J mice were treadmill-tested to measure indices defining exercise capacity on a metabolic chamber-enclosed treadmill capable of measuring oxygen uptake and carbon dioxide excretion. Urine was collected before and after treadmill exercise for determination of vascular NO production assessed by urinary nitrate excretion. The wild-type mice were then given nitro-L-arginine (E+LNA) in the drinking water (6 mg/dL) for 4 days before undergoing a second treadmill testing and urinary nitrate measurement. An additional set of 12-week-old wild-type mice was divided into 2 groups: 1 receiving regular water (E+; n=8) and 1 administered LNA for 4 days (E+LNA; n=8). These mice, along with an additional set of E mice (n=8), underwent treadmill testing to determine maximal oxygen uptake (VO2max). The mice were then cannulated such that the tip of the tubing was positioned in the ascending aorta. Fluorescent microspheres (20000) were infused into the carotid cannula while the mice were sedentary and again while approaching VO2max. When the mice were euthanized, the running muscles were collected and fluorescence intensity was measured to determine the peak-exercise redistribution of blood flow to the running muscles (expressed as percentage of total cardiac output, %COrm) during both states. Both E+LNA and E- mice demonstrated a markedly reduced postexercise urinary nitrate excretion, aerobic capacity, and %COrm at VO2max compared with E+. EDNO contributes significantly to limb blood flow during exercise. Conditions that reduce EDNO production disturb the hyperemic response to exercise, resulting in a reduced exercise capacity.
AbstractList BACKGROUND: We have recently reported that hypercholesterolemia reduces aerobic exercise capacity in mice and that this is associated with a reduced endothelium-dependent vasodilator function, endothelium-derived nitric oxide (EDNO) production, and urinary nitrate excretion. These findings led us to test the hypothesis that EDNO production contributes significantly to limb blood flow during exercise and to determine whether loss of EDNO production is responsible for the decline in exercise capacity observed in hypercholesterolemia. METHODS AND RESULTS: Twelve-week-old wild-type (E+; n=9) and apoE-deficient (E-; n=9) C57BL/6J mice were treadmill-tested to measure indices defining exercise capacity on a metabolic chamber-enclosed treadmill capable of measuring oxygen uptake and carbon dioxide excretion. Urine was collected before and after treadmill exercise for determination of vascular NO production assessed by urinary nitrate excretion. The wild-type mice were then given nitro-L-arginine (E+LNA) in the drinking water (6 mg/dL) for 4 days before undergoing a second treadmill testing and urinary nitrate measurement. An additional set of 12-week-old wild-type mice was divided into 2 groups: 1 receiving regular water (E+; n=8) and 1 administered LNA for 4 days (E+LNA; n=8). These mice, along with an additional set of E mice (n=8), underwent treadmill testing to determine maximal oxygen uptake (VO2max). The mice were then cannulated such that the tip of the tubing was positioned in the ascending aorta. Fluorescent microspheres (20000) were infused into the carotid cannula while the mice were sedentary and again while approaching VO2max. When the mice were euthanized, the running muscles were collected and fluorescence intensity was measured to determine the peak-exercise redistribution of blood flow to the running muscles (expressed as percentage of total cardiac output, %COrm) during both states. Both E+LNA and E- mice demonstrated a markedly reduced postexercise urinary nitrate excretion, aerobic capacity, and %COrm at VO2max compared with E+. CONCLUSIONS: EDNO contributes significantly to limb blood flow during exercise. Conditions that reduce EDNO production disturb the hyperemic response to exercise, resulting in a reduced exercise capacity.
We have recently reported that hypercholesterolemia reduces aerobic exercise capacity in mice and that this is associated with a reduced endothelium-dependent vasodilator function, endothelium-derived nitric oxide (EDNO) production, and urinary nitrate excretion. These findings led us to test the hypothesis that EDNO production contributes significantly to limb blood flow during exercise and to determine whether loss of EDNO production is responsible for the decline in exercise capacity observed in hypercholesterolemia. Twelve-week-old wild-type (E+; n=9) and apoE-deficient (E-; n=9) C57BL/6J mice were treadmill-tested to measure indices defining exercise capacity on a metabolic chamber-enclosed treadmill capable of measuring oxygen uptake and carbon dioxide excretion. Urine was collected before and after treadmill exercise for determination of vascular NO production assessed by urinary nitrate excretion. The wild-type mice were then given nitro-L-arginine (E+LNA) in the drinking water (6 mg/dL) for 4 days before undergoing a second treadmill testing and urinary nitrate measurement. An additional set of 12-week-old wild-type mice was divided into 2 groups: 1 receiving regular water (E+; n=8) and 1 administered LNA for 4 days (E+LNA; n=8). These mice, along with an additional set of E mice (n=8), underwent treadmill testing to determine maximal oxygen uptake (VO2max). The mice were then cannulated such that the tip of the tubing was positioned in the ascending aorta. Fluorescent microspheres (20000) were infused into the carotid cannula while the mice were sedentary and again while approaching VO2max. When the mice were euthanized, the running muscles were collected and fluorescence intensity was measured to determine the peak-exercise redistribution of blood flow to the running muscles (expressed as percentage of total cardiac output, %COrm) during both states. Both E+LNA and E- mice demonstrated a markedly reduced postexercise urinary nitrate excretion, aerobic capacity, and %COrm at VO2max compared with E+. EDNO contributes significantly to limb blood flow during exercise. Conditions that reduce EDNO production disturb the hyperemic response to exercise, resulting in a reduced exercise capacity.
BACKGROUNDWe have recently reported that hypercholesterolemia reduces aerobic exercise capacity in mice and that this is associated with a reduced endothelium-dependent vasodilator function, endothelium-derived nitric oxide (EDNO) production, and urinary nitrate excretion. These findings led us to test the hypothesis that EDNO production contributes significantly to limb blood flow during exercise and to determine whether loss of EDNO production is responsible for the decline in exercise capacity observed in hypercholesterolemia.METHODS AND RESULTSTwelve-week-old wild-type (E+; n=9) and apoE-deficient (E-; n=9) C57BL/6J mice were treadmill-tested to measure indices defining exercise capacity on a metabolic chamber-enclosed treadmill capable of measuring oxygen uptake and carbon dioxide excretion. Urine was collected before and after treadmill exercise for determination of vascular NO production assessed by urinary nitrate excretion. The wild-type mice were then given nitro-L-arginine (E+LNA) in the drinking water (6 mg/dL) for 4 days before undergoing a second treadmill testing and urinary nitrate measurement. An additional set of 12-week-old wild-type mice was divided into 2 groups: 1 receiving regular water (E+; n=8) and 1 administered LNA for 4 days (E+LNA; n=8). These mice, along with an additional set of E mice (n=8), underwent treadmill testing to determine maximal oxygen uptake (VO2max). The mice were then cannulated such that the tip of the tubing was positioned in the ascending aorta. Fluorescent microspheres (20000) were infused into the carotid cannula while the mice were sedentary and again while approaching VO2max. When the mice were euthanized, the running muscles were collected and fluorescence intensity was measured to determine the peak-exercise redistribution of blood flow to the running muscles (expressed as percentage of total cardiac output, %COrm) during both states. Both E+LNA and E- mice demonstrated a markedly reduced postexercise urinary nitrate excretion, aerobic capacity, and %COrm at VO2max compared with E+.CONCLUSIONSEDNO contributes significantly to limb blood flow during exercise. Conditions that reduce EDNO production disturb the hyperemic response to exercise, resulting in a reduced exercise capacity.
Background —We have recently reported that hypercholesterolemia reduces aerobic exercise capacity in mice and that this is associated with a reduced endothelium-dependent vasodilator function, endothelium-derived nitric oxide (EDNO) production, and urinary nitrate excretion. These findings led us to test the hypothesis that EDNO production contributes significantly to limb blood flow during exercise and to determine whether loss of EDNO production is responsible for the decline in exercise capacity observed in hypercholesterolemia. Methods and Results —Twelve-week-old wild-type (E + ; n=9) and apoE-deficient (E − ; n=9) C57BL/6J mice were treadmill-tested to measure indices defining exercise capacity on a metabolic chamber–enclosed treadmill capable of measuring oxygen uptake and carbon dioxide excretion. Urine was collected before and after treadmill exercise for determination of vascular NO production assessed by urinary nitrate excretion. The wild-type mice were then given nitro- l- arginine (E + LNA) in the drinking water (6 mg/dL) for 4 days before undergoing a second treadmill testing and urinary nitrate measurement. An additional set of 12-week-old wild-type mice was divided into 2 groups: 1 receiving regular water (E + ; n=8) and 1 administered LNA for 4 days (E + LNA; n=8). These mice, along with an additional set of E − mice (n=8), underwent treadmill testing to determine maximal oxygen uptake (V̇ o 2 max). The mice were then cannulated such that the tip of the tubing was positioned in the ascending aorta. Fluorescent microspheres (20 000) were infused into the carotid cannula while the mice were sedentary and again while approaching V̇ o 2 max. When the mice were euthanized, the running muscles were collected and fluorescence intensity was measured to determine the peak-exercise redistribution of blood flow to the running muscles (expressed as percentage of total cardiac output, %COrm) during both states. Both E + LNA and E − mice demonstrated a markedly reduced postexercise urinary nitrate excretion, aerobic capacity, and %COrm at V̇ o 2 max compared with E + . Conclusions —EDNO contributes significantly to limb blood flow during exercise. Conditions that reduce EDNO production disturb the hyperemic response to exercise, resulting in a reduced exercise capacity.
Author SCHAUBLE, E
BERNSTEIN, D
COOKE, J. P
MAXWELL, A. J
Author_xml – sequence: 1
  givenname: A. J
  surname: MAXWELL
  fullname: MAXWELL, A. J
  organization: Section of Vascular Medicine, Stanford University, Stanford, Calif, United States
– sequence: 2
  givenname: E
  surname: SCHAUBLE
  fullname: SCHAUBLE, E
  organization: Section of Vascular Medicine, Stanford University, Stanford, Calif, United States
– sequence: 3
  givenname: D
  surname: BERNSTEIN
  fullname: BERNSTEIN, D
  organization: Divisions of Cardiovascular Medicine and Pediatric Cardiology, Stanford University, Stanford, Calif, United States
– sequence: 4
  givenname: J. P
  surname: COOKE
  fullname: COOKE, J. P
  organization: Section of Vascular Medicine, Stanford University, Stanford, Calif, United States
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2343353$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/9711943$$D View this record in MEDLINE/PubMed
BookMark eNpdkM9LHDEUx0NRdLU991QIRXqbMT8nE-hFFtsKC4Wi55BJXkpkNlmTHbr-90ZcPPT0eHw_78vjc4FOUk6A0GdKekoHek1o72Lp9diLng_6A1pRyUQnJNcnaEUI0Z3ijJ2ji1of2zpwJc_QmVaUasFX6Psmbic8zTl7HOb8D_ulxPQXwwGKixVwrNjDDpKHtMc54RT3JTqcD9HDR3Qa7Fzh03Feoocft_frX93m98-79c2mc0LLfWeVYnYIFryV48i0VXKSkvvgbAjWEaGEH6XnmgqvOeWDhKm9KggETgc58Ev07a13V_LTAnVvtrE6mGebIC_VKD4Kxjhp4Nf_wMe8lNR-M4wyxYjkr23Xb5ArudYCwexK3NrybCgxr1INoWZ998fo0QjTpLaLL8faZdqCf-ePFlt-dcxtdXYOxabm7h1jvDGS8xfMP384
CODEN CIRCAZ
CitedBy_id crossref_primary_10_1096_fj_03_0792fje
crossref_primary_10_1007_s11883_001_0068_x
crossref_primary_10_1096_fj_10_158956
crossref_primary_10_1016_j_resp_2004_01_006
crossref_primary_10_6061_clinics_2012_03_12
crossref_primary_10_1152_ajpheart_00532_2003
crossref_primary_10_1097_HJH_0b013e3282f382ff
crossref_primary_10_1111_j_1440_1681_2005_04191_x
crossref_primary_10_1002_jmri_10407
crossref_primary_10_3390_nu9080917
crossref_primary_10_1002_jmri_10406
crossref_primary_10_1152_jappl_2001_90_3_933
crossref_primary_10_1002_ppul_22730
crossref_primary_10_2337_diacare_26_3_899
crossref_primary_10_4061_2009_927385
crossref_primary_10_1016_j_bbr_2017_03_044
crossref_primary_10_1016_j_jvs_2006_05_023
crossref_primary_10_1074_jbc_M109_021048
crossref_primary_10_1096_fj_99_0896rev
crossref_primary_10_1016_j_metabol_2003_09_010
crossref_primary_10_1177_10742484211042706
crossref_primary_10_1016_j_freeradbiomed_2015_04_006
crossref_primary_10_1016_S0735_1097_01_01142_1
crossref_primary_10_1152_ajpheart_00651_2003
crossref_primary_10_1152_ajpheart_00879_2002
crossref_primary_10_1093_eurheartj_ehi001
crossref_primary_10_1111_j_1751_7176_2009_00095_x
crossref_primary_10_1093_eurjhf_hfp053
crossref_primary_10_1016_j_amjcard_2011_08_014
crossref_primary_10_1113_expphysiol_2014_084095
crossref_primary_10_1152_jappl_1999_87_5_1948
crossref_primary_10_2165_00007256_200333140_00001
crossref_primary_10_1006_mvre_1999_2193
crossref_primary_10_1111_j_1469_7580_2008_00854_x
crossref_primary_10_1016_j_mri_2008_02_012
crossref_primary_10_1007_s40279_016_0596_8
crossref_primary_10_1191_1358863x05vm580oa
crossref_primary_10_1152_ajpendo_1999_277_2_E390
crossref_primary_10_3390_nu14214479
crossref_primary_10_1152_ajpheart_00519_2003
crossref_primary_10_1152_ajpheart_00267_2009
crossref_primary_10_1161_01_CIR_103_23_2773
crossref_primary_10_1152_ajpheart_1999_276_4_H1346
crossref_primary_10_1016_j_jacc_2011_11_082
crossref_primary_10_1016_j_ijcard_2008_11_014
crossref_primary_10_1152_ajpheart_00170_2005
crossref_primary_10_1097_HJR_0b013e3283361dc5
crossref_primary_10_1016_j_ijcard_2021_08_021
crossref_primary_10_14341_2072_0351_5759
crossref_primary_10_1117_1_JBO_23_3_035006
crossref_primary_10_3390_antiox13040432
crossref_primary_10_1038_srep24714
crossref_primary_10_1152_japplphysiol_00901_2002
crossref_primary_10_1152_ajpregu_00533_2015
crossref_primary_10_1113_jphysiol_2004_061283
crossref_primary_10_1249_JSR_0b013e31825e19cd
crossref_primary_10_1046_j_1440_1681_2000_03232_x
crossref_primary_10_1152_ajpregu_00004_2010
crossref_primary_10_1016_j_ejheart_2006_06_006
crossref_primary_10_1152_japplphysiol_00179_2004
crossref_primary_10_1113_jphysiol_2009_172916
crossref_primary_10_14814_phy2_12719
crossref_primary_10_1002_clc_4960240406
crossref_primary_10_1152_japplphysiol_00731_2007
crossref_primary_10_1089_acm_2008_0143
crossref_primary_10_1113_jphysiol_2004_068197
crossref_primary_10_1172_JCI9551
crossref_primary_10_1186_1476_7120_6_61
crossref_primary_10_3238_PersKardio_2015_09_18_02
crossref_primary_10_1155_2012_386387
crossref_primary_10_1002_jmri_20025
crossref_primary_10_1152_physiolgenomics_00188_2002
crossref_primary_10_1007_s00421_012_2439_0
crossref_primary_10_1016_j_niox_2017_07_006
crossref_primary_10_1016_S0021_9150_01_00629_3
crossref_primary_10_1111_j_1549_8719_2009_00014_x
crossref_primary_10_1177_1358863X08100040
crossref_primary_10_1016_S0024_3205_99_00299_4
crossref_primary_10_1016_j_vph_2007_04_002
crossref_primary_10_1253_circj_67_505
crossref_primary_10_1016_j_msom_2019_11_006
crossref_primary_10_1186_1476_9255_7_54
crossref_primary_10_1152_ajpheart_00360_2001
crossref_primary_10_1007_s10741_012_9323_1
crossref_primary_10_1007_s00421_016_3523_7
crossref_primary_10_1186_s12872_020_01484_3
crossref_primary_10_1002_jmri_10229
crossref_primary_10_1152_japplphysiol_00879_2002
crossref_primary_10_1152_ajpheart_00136_2004
crossref_primary_10_1111_j_1751_7133_2009_00093_x
crossref_primary_10_1186_1476_511X_13_40
crossref_primary_10_1007_s40618_020_01409_z
crossref_primary_10_1519_JSC_0b013e3181c6a14d
crossref_primary_10_1016_S1567_5688_03_00034_5
crossref_primary_10_15857_ksep_2015_24_3_233
crossref_primary_10_1155_2013_837130
crossref_primary_10_1007_s11897_018_0383_y
crossref_primary_10_1152_ajpheart_00697_2019
Cites_doi 10.1161/circ.90.6.7994830
10.1016/0009-8981(73)90466-X
10.1007/BF00392036
10.1152/jappl.1993.75.6.2740
10.1146/annurev.ph.58.030196.000321
10.1161/res.67.2.2115825
10.1016/S0735-1097(97)85610-0
10.1161/circ.89.5.8181143
10.1242/jeb.115.1.319
10.1161/res.72.6.8495555
10.1093/clinchem/20.4.470
10.1073/pnas.89.10.4471
10.1152/jappl.1992.72.3.954
10.1152/jappl.1991.71.4.1387
10.1113/jphysiol.1995.sp020964
10.1007/978-1-4757-2296-3_15
10.1016/0300-9629(80)90001-8
10.1177/174182679400100212
10.1378/chest.101.5_Supplement.188S
10.1161/circ.90.6.7994834
10.1016/0014-5793(95)00763-Y
10.1152/jappl.1986.60.6.2020
10.1093/cvr/28.4.494
10.1378/chest.101.5_Supplement.223S
ContentType Journal Article
Copyright 1998 INIST-CNRS
Copyright American Heart Association, Inc. Jul 28, 1998
Copyright_xml – notice: 1998 INIST-CNRS
– notice: Copyright American Heart Association, Inc. Jul 28, 1998
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
K9.
NAPCQ
U9A
7X8
DOI 10.1161/01.cir.98.4.369
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Career and Technical Education (Alumni Edition)
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)
MEDLINE
MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1524-4539
EndPage 374
ExternalDocumentID 35298653
10_1161_01_CIR_98_4_369
9711943
2343353
Genre Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S
Journal Article
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: 1RO1-HL-58638
GroupedDBID ---
.-D
.3C
.55
.GJ
.XZ
.Z2
01R
08R
0R~
0ZK
18M
1CY
1J1
29B
2FS
2WC
354
40H
41~
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
6PF
71W
77Y
7O~
AAAXR
AAEJM
AAGIX
AAHPQ
AAJCS
AAMOA
AAMTA
AAPBV
AAQKA
AARTV
AASOK
AASXQ
AAUGY
AAWTL
AAXQO
AAYOK
ABASU
ABBUW
ABDIG
ABOCM
ABPMR
ABPTK
ABQRW
ABXVJ
ABZAD
ACCJW
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACOAL
ACRKK
ACRZS
ACWDW
ACWRI
ACXNZ
ADBBV
ADCYY
ADFPA
ADGGA
ADNKB
AE3
AE6
AEBDS
AEETU
AENEX
AFCHL
AFDTB
AFFNX
AFUWQ
AGINI
AHMBA
AHOMT
AHRYX
AHVBC
AIJEX
AJIOK
AJJEV
AJNWD
AJNYG
AKALU
AKULP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
ASPBG
AVWKF
AWKKM
AYCSE
AZFZN
BAWUL
BOYCO
BQLVK
BS7
BYPQX
C1A
C45
CS3
DIK
DIWNM
DU5
DUNZO
E.X
E3Z
EBS
EEVPB
EJD
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FEDTE
FL-
FW0
GNXGY
GQDEL
GX1
H0~
H13
HZ~
H~9
IKREB
IKYAY
IN~
IPNFZ
IQODW
J5H
JF9
JG8
JK3
JK8
K-A
K-F
K8S
KD2
KMI
KQ8
L-C
L7B
M18
MVM
N4W
N9A
NEJ
N~7
N~B
N~M
O9-
OAG
OAH
OBH
OCB
OCUKA
ODA
ODMTH
OGEVE
OHH
OHT
OHYEH
OJAPA
OK1
OL1
OLB
OLG
OLH
OLU
OLV
OLW
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWBYB
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
PQQKQ
R58
RAH
RHF
RIG
RLZ
S4R
S4S
T8P
TEORI
TR2
TSPGW
UPT
V2I
VVN
W2D
W3M
W8F
WH7
WHG
WOQ
WOW
X3V
X3W
X7M
XXN
XYM
YFH
YOC
YQJ
YSK
YXB
YYM
YYP
YZZ
ZA5
ZFV
ZGI
ZXP
ZY1
ZZMQN
~H1
AAAAV
AAIQE
AAUEB
ABJNI
ADHPY
AFEXH
AHQNM
AINUH
AJZMW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
K9.
NAPCQ
U9A
7X8
ID FETCH-LOGICAL-c495t-a772a6faeda58829a75b553dfcaffac0474d85d3914d931365eb00040ef316563
ISSN 0009-7322
IngestDate Fri Oct 25 02:52:06 EDT 2024
Thu Oct 10 16:35:51 EDT 2024
Fri Aug 23 01:07:14 EDT 2024
Wed Oct 16 00:50:46 EDT 2024
Sun Oct 29 17:06:56 EDT 2023
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Physical exercise
Pathogenesis
Rodentia
Metabolic diseases
Lipids
Hyperlipoproteinemia
Blood flow
Vertebrata
Mammalia
Hypercholesterolemia
Mouse
Animal
Nitric oxide
Limb
Complication
Dyslipemia
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c495t-a772a6faeda58829a75b553dfcaffac0474d85d3914d931365eb00040ef316563
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.98.4.369
PMID 9711943
PQID 212720536
PQPubID 24119
PageCount 6
ParticipantIDs proquest_miscellaneous_73842230
proquest_journals_212720536
crossref_primary_10_1161_01_CIR_98_4_369
pubmed_primary_9711943
pascalfrancis_primary_2343353
PublicationCentury 1900
PublicationDate 1998-07-28
PublicationDateYYYYMMDD 1998-07-28
PublicationDate_xml – month: 07
  year: 1998
  text: 1998-07-28
  day: 28
PublicationDecade 1990
PublicationPlace Hagerstown, MD
PublicationPlace_xml – name: Hagerstown, MD
– name: United States
– name: Baltimore
PublicationTitle Circulation (New York, N.Y.)
PublicationTitleAlternate Circulation
PublicationYear 1998
Publisher Lippincott Williams & Wilkins
American Heart Association, Inc
Publisher_xml – name: Lippincott Williams & Wilkins
– name: American Heart Association, Inc
References e_1_3_2_26_2
(e_1_3_2_15_2) 1992; 263
e_1_3_2_27_2
e_1_3_2_28_2
e_1_3_2_29_2
(e_1_3_2_17_2) 1980; 239
(e_1_3_2_4_2) 1996; 45
e_1_3_2_20_2
e_1_3_2_21_2
e_1_3_2_22_2
e_1_3_2_25_2
(e_1_3_2_10_2) 1994; 266
(e_1_3_2_32_2) 1975; 7
e_1_3_2_9_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_7_2
e_1_3_2_6_2
e_1_3_2_18_2
(e_1_3_2_19_2) 1994; 267
e_1_3_2_1_2
(e_1_3_2_23_2) 1996; 271
(e_1_3_2_24_2) 1996; 270
e_1_3_2_31_2
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_12_2
e_1_3_2_33_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_2_2
e_1_3_2_14_2
(e_1_3_2_30_2) 1995; 27
References_xml – ident: e_1_3_2_27_2
  doi: 10.1161/circ.90.6.7994830
– volume: 266
  start-page: E519
  year: 1994
  ident: e_1_3_2_10_2
  publication-title: Am J Physiol
– ident: e_1_3_2_13_2
  doi: 10.1016/0009-8981(73)90466-X
– ident: e_1_3_2_9_2
  doi: 10.1007/BF00392036
– ident: e_1_3_2_28_2
  doi: 10.1152/jappl.1993.75.6.2740
– ident: e_1_3_2_31_2
  doi: 10.1146/annurev.ph.58.030196.000321
– ident: e_1_3_2_20_2
  doi: 10.1161/res.67.2.2115825
– ident: e_1_3_2_1_2
  doi: 10.1016/S0735-1097(97)85610-0
– volume: 270
  start-page: H1435
  year: 1996
  ident: e_1_3_2_24_2
  publication-title: Am J Physiol
– volume: 27
  start-page: 47
  year: 1995
  ident: e_1_3_2_30_2
  publication-title: Med Sci Sports Exerc
– volume: 263
  start-page: R728
  year: 1992
  ident: e_1_3_2_15_2
  publication-title: Am J Physiol
– ident: e_1_3_2_7_2
– ident: e_1_3_2_12_2
  doi: 10.1161/circ.89.5.8181143
– ident: e_1_3_2_33_2
  doi: 10.1242/jeb.115.1.319
– ident: e_1_3_2_21_2
  doi: 10.1161/res.72.6.8495555
– ident: e_1_3_2_16_2
  doi: 10.1093/clinchem/20.4.470
– ident: e_1_3_2_2_2
  doi: 10.1073/pnas.89.10.4471
– ident: e_1_3_2_8_2
  doi: 10.1152/jappl.1992.72.3.954
– volume: 239
  start-page: H443
  year: 1980
  ident: e_1_3_2_17_2
  publication-title: Am J Physiol
– ident: e_1_3_2_14_2
  doi: 10.1152/jappl.1991.71.4.1387
– volume: 7
  start-page: 116
  year: 1975
  ident: e_1_3_2_32_2
  publication-title: Med Sci Sports Exerc
– ident: e_1_3_2_25_2
  doi: 10.1113/jphysiol.1995.sp020964
– ident: e_1_3_2_22_2
  doi: 10.1007/978-1-4757-2296-3_15
– ident: e_1_3_2_6_2
  doi: 10.1016/0300-9629(80)90001-8
– ident: e_1_3_2_11_2
  doi: 10.1177/174182679400100212
– ident: e_1_3_2_29_2
  doi: 10.1378/chest.101.5_Supplement.188S
– volume: 271
  start-page: H1182
  year: 1996
  ident: e_1_3_2_23_2
  publication-title: Am J Physiol
– ident: e_1_3_2_26_2
  doi: 10.1161/circ.90.6.7994834
– ident: e_1_3_2_34_2
  doi: 10.1016/0014-5793(95)00763-Y
– volume: 45
  start-page: 323
  year: 1996
  ident: e_1_3_2_4_2
  publication-title: Physiol Res
– ident: e_1_3_2_5_2
  doi: 10.1152/jappl.1986.60.6.2020
– ident: e_1_3_2_3_2
  doi: 10.1093/cvr/28.4.494
– ident: e_1_3_2_18_2
  doi: 10.1378/chest.101.5_Supplement.223S
– volume: 267
  start-page: H326
  year: 1994
  ident: e_1_3_2_19_2
  publication-title: Am J Physiol
SSID ssj0006375
Score 1.9784647
Snippet We have recently reported that hypercholesterolemia reduces aerobic exercise capacity in mice and that this is associated with a reduced endothelium-dependent...
Background —We have recently reported that hypercholesterolemia reduces aerobic exercise capacity in mice and that this is associated with a reduced...
BACKGROUND: We have recently reported that hypercholesterolemia reduces aerobic exercise capacity in mice and that this is associated with a reduced...
BACKGROUNDWe have recently reported that hypercholesterolemia reduces aerobic exercise capacity in mice and that this is associated with a reduced...
SourceID proquest
crossref
pubmed
pascalfrancis
SourceType Aggregation Database
Index Database
StartPage 369
SubjectTerms Animals
Apolipoproteins E - deficiency
Biological and medical sciences
Disorders of blood lipids. Hyperlipoproteinemia
Enzyme Inhibitors - pharmacology
Extremities - blood supply
Female
Hypercholesterolemia - metabolism
Hypercholesterolemia - physiopathology
Hyperemia - etiology
Hyperemia - physiopathology
Medical sciences
Metabolic diseases
Mice
Mice, Inbred C57BL
Motor Activity - physiology
Nitrates - urine
Nitric Oxide - physiology
Nitroarginine - pharmacology
Physical Endurance - physiology
Regional Blood Flow - physiology
Title Limb blood flow during exercise is dependent on nitric oxide
URI https://www.ncbi.nlm.nih.gov/pubmed/9711943
https://www.proquest.com/docview/212720536
https://search.proquest.com/docview/73842230
Volume 98
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9NAEF_0BBFE9M7Dep7ug4ggiUl287HgSyl3nNKeKC30bdlsslzAS442xdO_3tndbJrqiR8voaTNJuz8ZjLT-fgh9FKHOrnMCw-cdU1hpqSXs0R5IhWaC57EwoxjmJ0nZwv6YRkvHWd7113S5r78fmNfyf9IFc6BXHWX7D9Itl8UTsBnkC8cQcJw_CsZT6vL3Jaev1Ffmq-u59DRKGmyckdy2-qsAKivLpxvrqtid0RBtZIdjddN7DyDfwtm4tqVUY8HGSV5ITa5LUzeTu4sV-B6dlyafV3xpB_x2XWWFdsWvNR1cDsryryURDtWlGUDtNCBSSSWiqV7uxLLyfOr4U5C04zgy2rls8ynfn_dcET2-Ud-uphO-fxkOb-N7kR6up_OxH_ajohPSBo7-jz9kN08J7jB25-W33FF7l-JNWiFsnQmv483jN8xf4gedAEDHlvpP0K3ynofHYxr0TaX3_ArbEp4TW5kH92ddZUSB-idxgY22MAaG9hiAzts4GqNe2zgpsYWG9hg4zFanJ7MJ2dex5ThSQhwW9CsNBKJEmUhYgiZmEjjPI5JoaRQSsiAprTI4oKwkBaM6MrG0njzQamIHr9EDtFe3dTlE4QzBUoKro1IioDmOm2aChXLUolMKkWDEXrtNo1f2YEo3ASSSciDkE_ef-Ys45TD_o7Q8c6m9r-PCCUkJiN05DaZd1q15ppxIII3QzJCL_pvweTpPJaoy2az5inJKHi18CiHVjL9wiwNQ0bJ0z9eeoTubZH9DO21q015DN5lmz83aPoBp7J2_Q
link.rule.ids 315,783,787,27937,27938
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Limb+blood+flow+during+exercise+is+dependent+on+nitric+oxide&rft.jtitle=Circulation+%28New+York%2C+N.Y.%29&rft.au=Maxwell%2C+A+J&rft.au=Schauble%2C+E&rft.au=Bernstein%2C+D&rft.au=Cooke%2C+J+P&rft.date=1998-07-28&rft.issn=0009-7322&rft.volume=98&rft.issue=4&rft.spage=369&rft.epage=374&rft_id=info:doi/10.1161%2F01.cir.98.4.369&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-7322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-7322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-7322&client=summon